Immunotherapeutic aryl amides
US5801195A · kind A · utility
61Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 1994 |
| Grant date | Sep 1, 1998 |
| Priority date | — |
| Expiry date | Dec 30, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel aryl amides are inhibitors of tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is N-benzoyl-3-amino-3-(3',4'-dimethoxyphenyl)propanamide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.